Multitarget AD-IN-7
Multitarget AD-IN-7 is an orally active multi-target anti-AD compound. Multitarget AD-IN-7 exhibits inhibitory activity against GSK-3β and GSK-3α (IC50 = 0.66, 0.83 nM). Multitarget AD-IN-7 upregulates the expression of p-GSK-3β-Ser9, inhibits the phosphorylation of tau-Ser396, targets Aβ1-42, chelates pathogenic metal ions, scavenges ABTS•+, upregulates the expression of β-catenin and neurogenesis biomarkers, and promotes neurite outgrowth. Multitarget AD-IN-7 improves motor ability in Alzheimer's disease zebrafish. Multitarget AD-IN-7 is applicable to research related to Alzheimer's disease.
For research use only. We do not sell to patients.
- CAS No.: 3113741-59-3
- Formula: C28H19N5O2
- Molecular Weight:457.48
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
GSK-3β 0.66 nM (IC50) |
GSK-3α 0.83 nM (IC50) |
In Vitro
Multitarget AD-IN-7 (Compound 3c) exhibits excellent selectivity for GSK-3β/α in a screening panel consisting of 24 kinases, with an IC50 of 0.83 nM against GSK-3α and an IC50 of 928 nM against CDK5/p35[1].
Multitarget AD-IN-7 (1-10 μM; 2.5 h) upregulates the level of p-GSK-3β-Ser9, thereby inactivating GSK-3β in SH-SY5Y cells, and upregulates the level of β-catenin in SH-SY5Y cells[1].
Multitarget AD-IN-7 (1-10 μM; 1 h pre-incubation prior to 6 h Aβ25-35 stimulation) inhibits Aβ25-35 (HY-P0128)-induced tau-Ser396 phosphorylation in SH-SY5Y cells in a concentration-dependent manner in vitro[1].
Multitarget AD-IN-7 (10 μM; 24 h) upregulates the mRNA expression levels of neurogenesis-related biomarkers GAP-43 and MAP-2 in SH-SY5Y cells[1].
Multitarget AD-IN-7 (1 μM; 72 h) promotes axonal growth in SH-SY5Y cells, increasing the proportion of cells with axons to 44.11%[1].
Multitarget AD-IN-7 (20 μM mixed with 40 μM metal ions; 30 min at ambient temperature) exhibits strong chelation with Alzheimer's disease (AD)-related metal ions Fe2+, Zn2+, Cu2+ and Al3+ (but does not chelate Na+, K+, Mg2+ or Ca2+)[1].
Multitarget AD-IN-7 (20 μM mixed with 20 μM Aβ1-42; 24 h at 37 °C) inhibits the self-aggregation of Aβ1-42 with an inhibition rate of 33.35% and disaggregates preformed Aβ1-42 aggregates by 46.48%, as detected by ThT fluorescence assay and transmission electron microscopy (TEM)[1].
Multitarget AD-IN-7 (20 μM mixed with 20 μM Aβ1-42 and 20 μM Cu2+; 24 h at 37 °C) exhibits 52.18% inhibition of Cu2+-mediated Aβ1-42 aggregation and achieves a 56.12% disaggregation rate of preformed Cu2+-Aβ1-42 aggregates, as determined by ThT fluorescence assay[1].
Multitarget AD-IN-7 exhibits an IC50 of 7.04 μM for scavenging ABTS•+[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SH-SY5Y cells
-
Concentration:1, 5, 10 μM
-
Incubation Time:2.5 h
-
Result:Increased p-GSK-3β-Ser9 levels in a concentration-dependent manner, with p-GSK-3β-Ser9/GAPDH ratios of 0.43, 0.63, and 0.76 for 1, 5, 10 μM, respectively.\nIncreased β-catenin levels in a concentration-dependent manner, with β-catenin/GAPDH ratios of 0.32, 0.39, and 0.51 for 1, 5, 10 μM, respectively.
-
Cell Line:SH-SY5Y cells
-
Concentration:1, 5, 10 μM
-
Incubation Time:1 h (pre-incubation before 6 h Aβ25-35 stimulation)
-
Result:Decreased p-tau-Ser396 levels in a concentration-dependent manner, with p-tau-Ser396/GAPDH ratios of 0.31, 0.24, and 0.18 for 1, 5, 10 μM, respectively.
-
Cell Line:SH-SY5Y cells
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Upregulated mRNA expression of GAP-43 and MAP-2 to levels greater than the positive control retinoic acid.
In Vivo
Multitarget AD-IN-7 (1000 mg/kg; p.o.; single dose) exhibits low acute toxicity in C57BL/6 mice. No mortality, behavioral abnormalities, body weight changes or organ pathological alterations are observed within 14 days after a single oral dose of 1000 mg/kg[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:AB wild-type (juvenile, 4 days post-fertilization)[1]
-
Dosage:1.95 μM; 3.91 μM; 7.81 μM
-
Administration:water exposure; 24 h
-
Result:Increased swimming distance of AlCl3-induced AD zebrafish to 1314 mm at 1.95 μM.
Increased swimming distance of AlCl3-induced AD zebrafish to 1716 mm at 3.91 μM.
Increased swimming distance of AlCl3-induced AD zebrafish to 2040 mm at 7.81 μM, compared to the AlCl3-induced control distance of 996 mm.
-
Animal Model:C57BL/6 (6-8 weeks old, male and female)[1]
-
Dosage:1000 mg/kg
-
Administration:p.o.; single dose
-
Result:Observed no mortalities or abnormal behaviors over 14 days.
Showed no marked body weight changes compared to controls.
Observed no noticeable size or shape differences in dissected organs (heart, liver, spleen, lung, kidney, brain).
Revealed no significant pathological changes in organs via H&E staining.
Chemical Information
-
CAS No. 3113741-59-3
-
Molecular Weight 457.48
-
Formula C28H19N5O2
-
SMILES
OC1=CC(C2=CN=C(NC=C3C(NC4=C(C5=CC=CC=C5)C=CN=C4)=O)C3=C2)=CC6=C1N=CC=C6
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
PC12 NGF-Induced Neuronal Differentiation Culture
PC12 cells are a rat adrenal pheochromocytoma clonal line that responds to NGF by stopping proliferation and extending branching neurite-like processes; after longer NGF exposure, cells develop long processes and neuronal-like ultrastructural and functional features. NGF-induced differentiation is read out mainly by neurite outgrowth, reduced proliferation, microtubule assembly, and neuronal differentiation-associated proteins such as MAPs, tau, GAP-43, and synapsin-1.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
SH-SY5Y Neuronal Differentiation Culture
SH-SY5Y neuronal differentiation culture uses sequential exposure to retinoic acid and neurotrophic factors to reduce proliferative neuroblastoma-like behavior and induce neuron-like morphology, including neurite extension, neuronal marker expression, and, in RA/BDNF protocols, greater synaptic-marker expression than undifferentiated culture. Retinoic acid is commonly used as the initiating differentiation cue, while BDNF in serum-reduced or serum-free medium supports later maturation and neurotrophic-factor-dependent neuron-like survival.
-
SH-SY5Y neuronal-like differentiation
SH-SY5Y neuronal-like differentiation uses defined culture conditions to shift proliferative human neuroblastoma cells toward a neuron-like state, mainly assessed by reduced proliferation, neurite extension, neuronal-marker expression, and, in some protocols, increased dependence on neurotrophic support. Retinoic acid (RA) is commonly used for the first differentiation phase, and sequential RA followed by brain-derived neurotrophic factor (BDNF) in serum-free medium is a well-characterized approach for generating neuron-like SH-SY5Y cultures with extensive neurite outgrowth. The primary readouts are morphology-based neurite outgrowth and marker-based confirmation using proteins such as βIII-tubulin, MAP2, GAP43, synaptophysin, NeuN, NSE, TH, or related neuronal/synaptic markers, depending on the study endpoint.
-
Cell differentiation
Cell differentiation refers to the process in which cells of the same origin gradually produce cell groups with different morphological structure and functional characteristics.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
PC12 NGF-induced neuronal-like differentiation
PC12 cells are a rat adrenal pheochromocytoma-derived clonal cell line that responds to nerve growth factor by stopping proliferation and extending neurites, producing a sympathetic neuron-like phenotype used to study neuronal differentiation and neurite outgrowth. NGF acts through TrkA-dependent signaling, and neurite outgrowth is associated with ERK/Akt signaling, microtubule organization, neuronal-marker expression, and increased electrophysiological neuronal features such as sodium-channel density. The main assay readout is morphological differentiation, usually measured as the percentage of neurite-bearing cells, neurite length, neurite number, or total neurite length per cell. Additional readouts include GAP-43, tyrosine hydroxylase, βIII-tubulin, neurofilament, synapsin I, synaptophysin, ERK phosphorylation, Akt phosphorylation, and sodium-channel current density.
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)